The Truth About Skin Care

Main Category: Melanoma / Skin Cancer
Also Included In: Dermatology;  Cancer / Oncology
Article Date: 26 May 2010 – 6:00 PDT

email to a friend   printer friendly   view / write opinions
<!–   rate article

NICE has published updated recommendations on the diagnosis and removal of ‘low risk’ basal cell carcinomas (BCCs) in primary care [...]

Initial treatment with twice weekly etanercept (Enbrel), a tumour necrosis factor antagonist, achieves more rapid clearance of skin lesions than once weekly treatment in patients with active psoriasis and psoriatic arthritis, according to results from the PRESTA study reported recently in the British Medical Journal…

Heparin, a commonly used anticoagulant, can cause skin lesions, reports a study http://www.cmaj.ca/press/cmaj081729.pdf in CMAJ (Canadian Medical Association Journal). Skin lesions caused by heparin may indicate the presence of a life-threatening decrease in the number of platelets, a condition called “heparin-induced thrombocytopenia” or, in most cases, a self-limiting, allergic skin reaction.

Dermatitis, benign moles, hives and cancerous skin lesions are among the most common diagnoses among military personnel who were evacuated from combat zones for ill-defined dermatologic diseases, according to a report in the February issue of Archives of Dermatology, one of the JAMA/Archives journals.

The drug ustekinumab reduces symptoms of psoriatic arthritis (PA) and diminishes skin lesions compared with placebo. These are the conclusions of an Article published Online First and in an upcoming edition of The Lancet, written by Dr Alice Gottlieb, Department of Dermatology, Tufts Medical Center, Boston, MA, USA, and colleagues. PA is a [...]